vimarsana.com

Page 10 - கைபேசி நோக்கியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pembrolizumab regimen safe, effective in relapsed or refractory Hodgkin lymphoma

Pembrolizumab plus gemcitabine, vinorelbine and liposomal doxorubicin demonstrated substantial efficacy as second-line therapy among patients with relapsed or refractory classical Hodgkin lymphoma, according to phase 2 study results.The findings, published in Journal of Clinical Oncology, also showed the combination had a favorable toxicity profile.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.